$78.62
Insights on Encompass Health Corporation
Revenue is up for the last 6 quarters, 1.08B → 1.24B (in $), with an average increase of 2.7% per quarter
Netprofit is up for the last 2 quarters, 85.3M → 87.6M (in $), with an average increase of 2.6% per quarter
In the last 1 year, Davita Healthcare Partners Inc. has given 52.9% return, outperforming this stock by 23.7%
In the last 3 years, Tenet Healthcare Corp. has given 12.8% return, outperforming this stock by 19.0%
0.09%
Downside
Day's Volatility :1.27%
Upside
1.18%
27.11%
Downside
52 Weeks Volatility :31.55%
Upside
6.1%
Period | Encompass Health Corporation | Sector (Health Care) | Index (Russel 2000) |
---|---|---|---|
3 Months | 12.46% | -0.7% | 0.0% |
6 Months | 23.99% | 6.6% | 0.0% |
1 Year | 29.16% | 3.7% | -1.5% |
3 Years | -6.42% | 14.0% | -21.8% |
Market Capitalization | 8.0B |
Book Value | $16.43 |
Dividend Share | 0.6 |
Dividend Yield | 0.74% |
Earnings Per Share (EPS) | 3.59 |
PE Ratio | 22.28 |
Wall Street Target Price | 88.1 |
Profit Margin | 7.33% |
Operating Margin TTM | 15.23% |
Return On Assets TTM | 7.79% |
Return On Equity TTM | 22.84% |
Revenue TTM | 4.8B |
Revenue Per Share TTM | 48.25 |
Quarterly Revenue Growth YOY | 9.6% |
Gross Profit TTM | 1.8B |
EBITDA | 1.0B |
Diluted Eps TTM | 3.59 |
Quarterly Earnings Growth YOY | -0.03 |
EPS Estimate Current Year | 3.97 |
EPS Estimate Next Year | 4.4 |
EPS Estimate Current Quarter | 0.82 |
EPS Estimate Next Quarter | 0.91 |
What analysts predicted
Upside of 12.06%
FY18 | Y/Y Change | |
---|---|---|
Revenue | 4.3B | ↑ 9.14% |
Net Income | 292.3M | ↑ 14.05% |
Net Profit Margin | 6.83% | ↑ 0.29% |
FY19 | Y/Y Change | |
---|---|---|
Revenue | 4.6B | ↑ 7.66% |
Net Income | 358.7M | ↑ 22.72% |
Net Profit Margin | 7.79% | ↑ 0.96% |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 4.6B | ↑ 0.86% |
Net Income | 284.2M | ↓ 20.77% |
Net Profit Margin | 6.12% | ↓ 1.67% |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 5.1B | ↑ 10.27% |
Net Income | 412.2M | ↑ 45.04% |
Net Profit Margin | 8.05% | ↑ 1.93% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 4.3B | ↓ 15.09% |
Net Income | 271.0M | ↓ 34.26% |
Net Profit Margin | 6.23% | ↓ 1.82% |
FY23 | Y/Y Change | |
---|---|---|
Revenue | 4.8B | ↑ 10.41% |
Net Income | 352.0M | ↑ 29.89% |
Net Profit Margin | 7.33% | ↑ 1.1% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Revenue | 1.1B | ↓ 18.11% |
Net Income | 85.5M | ↑ 19.92% |
Net Profit Margin | 7.85% | ↑ 2.49% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Revenue | 1.1B | ↑ 4.39% |
Net Income | 89.4M | ↑ 4.56% |
Net Profit Margin | 7.86% | ↑ 0.01% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Revenue | 1.2B | ↑ 2.03% |
Net Income | 87.7M | ↓ 1.9% |
Net Profit Margin | 7.56% | ↓ 0.3% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Revenue | 1.2B | ↑ 2.3% |
Net Income | 91.4M | ↑ 4.22% |
Net Profit Margin | 7.7% | ↑ 0.14% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Revenue | 1.2B | ↑ 1.67% |
Net Income | 85.3M | ↓ 6.67% |
Net Profit Margin | 7.07% | ↓ 0.63% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Revenue | 1.2B | ↑ 3.31% |
Net Income | 87.6M | ↑ 2.7% |
Net Profit Margin | 7.03% | ↓ 0.04% |
FY18 | Y/Y Change | |
---|---|---|
Total Assets | 5.2B | ↑ 6.82% |
Total Liabilities | 3.4B | ↑ 3.33% |
FY19 | Y/Y Change | |
---|---|---|
Total Assets | 6.1B | ↑ 16.32% |
Total Liabilities | 4.1B | ↑ 23.59% |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 6.4B | ↑ 6.01% |
Total Liabilities | 4.4B | ↑ 7.14% |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 6.9B | ↑ 6.5% |
Total Liabilities | 4.5B | ↑ 0.48% |
FY22 | Y/Y Change | |
---|---|---|
Total Assets | 5.6B | ↓ 17.89% |
Total Liabilities | 3.8B | ↓ 15.48% |
FY23 | Y/Y Change | |
---|---|---|
Total Assets | 6.1B | ↑ 8.27% |
Total Liabilities | 3.8B | ↑ 0.81% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 5.5B | ↓ 22.68% |
Total Liabilities | 3.7B | ↓ 17.84% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 5.6B | ↑ 2.93% |
Total Liabilities | 3.8B | ↑ 1.25% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 5.7B | ↑ 1.97% |
Total Liabilities | 3.8B | ↑ 0.25% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 5.9B | ↑ 1.98% |
Total Liabilities | 3.8B | ↑ 0.52% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 6.0B | ↑ 1.76% |
Total Liabilities | 3.8B | ↓ 0.76% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 6.1B | ↑ 2.32% |
Total Liabilities | 3.8B | ↑ 0.8% |
FY18 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 762.4M | ↑ 16.01% |
Investing Cash Flow | -424.5M | ↑ 49.21% |
Financing Cash Flow | -321.2M | ↓ 10.48% |
FY19 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 635.3M | ↓ 16.67% |
Investing Cash Flow | -657.4M | ↑ 54.86% |
Financing Cash Flow | 48.2M | ↓ 115.01% |
FY20 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 704.7M | ↑ 10.92% |
Investing Cash Flow | -407.5M | ↓ 38.01% |
Financing Cash Flow | -145.9M | ↓ 402.7% |
FY21 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 715.8M | ↑ 1.58% |
Investing Cash Flow | -666.3M | ↑ 63.51% |
Financing Cash Flow | -240.1M | ↑ 64.56% |
FY22 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 705.8M | ↓ 1.4% |
Investing Cash Flow | -627.0M | ↓ 5.9% |
Financing Cash Flow | -145.7M | ↓ 39.32% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 70.1M | ↓ 71.34% |
Investing Cash Flow | -174.3M | ↑ 41.48% |
Financing Cash Flow | -49.0M | ↑ 153.89% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 172.2M | ↑ 145.65% |
Investing Cash Flow | -627.0M | ↑ 259.72% |
Financing Cash Flow | -16.5M | ↓ 66.33% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 227.9M | ↑ 32.35% |
Investing Cash Flow | -104.0M | ↓ 83.41% |
Financing Cash Flow | -58.0M | ↑ 251.52% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 206.7M | ↓ 9.3% |
Investing Cash Flow | -128.5M | ↑ 23.56% |
Financing Cash Flow | -43.5M | ↓ 25.0% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 215.2M | ↑ 4.11% |
Investing Cash Flow | -394.7M | ↑ 207.16% |
Financing Cash Flow | -65.8M | ↑ 51.26% |
Sell
Neutral
Buy
Encompass Health Corporation is currently in a neutral trading position according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
Encompass Health Corporation | 4.87% | 23.99% | 29.16% | -6.42% | 30.06% |
Fresenius Medical Care Ag | -0.32% | 10.42% | -15.35% | -50.85% | -51.82% |
Hca Holdings, Inc. | -4.93% | 28.25% | 14.58% | 59.59% | 169.9% |
Tenet Healthcare Corp. | -4.36% | 72.26% | 44.71% | 82.68% | 310.08% |
Universal Health Services Inc. | -9.74% | 24.99% | 16.98% | 9.58% | 28.53% |
Davita Healthcare Partners Inc. | -6.85% | 62.1% | 52.88% | 15.22% | 144.38% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
Encompass Health Corporation | 22.28 | 22.28 | NA | 3.97 | 0.23 | 0.08 | 0.01 | 16.43 |
Fresenius Medical Care Ag | 20.44 | 20.44 | 0.39 | 2.04 | 0.05 | 0.03 | 0.03 | 46.42 |
Hca Holdings, Inc. | 17.0 | 17.0 | 1.44 | 20.64 | 0.12 | 0.11 | 0.01 | -6.68 |
Tenet Healthcare Corp. | 17.21 | 17.21 | 2.2 | 6.03 | 0.26 | 0.06 | NA | 16.09 |
Universal Health Services Inc. | 16.27 | 16.27 | 1.87 | 13.45 | 0.12 | 0.05 | 0.0 | 91.53 |
Davita Healthcare Partners Inc. | 17.49 | 17.49 | 1.16 | 9.01 | 0.39 | 0.06 | NA | 11.89 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
Encompass Health Corporation | Buy | $8.0B | 30.06% | 22.28 | 7.33% |
Fresenius Medical Care Ag | Hold | $10.9B | -51.82% | 20.44 | 2.57% |
Hca Holdings, Inc. | Buy | $85.3B | 169.9% | 17.0 | 8.07% |
Tenet Healthcare Corp. | Buy | $9.7B | 310.08% | 17.21 | 2.97% |
Universal Health Services Inc. | Hold | $11.2B | 28.53% | 16.27 | 5.03% |
Davita Healthcare Partners Inc. | Hold | $11.3B | 144.38% | 17.49 | 5.7% |
Vanguard Group Inc
BlackRock Inc
Wellington Management Company LLP
William Blair Investment Management, LLC
Amvescap Plc.
State Street Corporation
In the quarter ending March,2023. Encompass Health Corporation has declared dividend of $0.15
Read Moreas a national leader of post-acute care, encompass health offers facility-based and home-based patient care through our network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. we are committed to delivering high-quality, cost-effective care across the post-acute continuum. driven by a set of shared values, encompass health is the result of the union between healthsouth corporation and encompass home health & hospice.our approach to post-acute care sets us apart. we firmly believe that every success starts with our dedicated team of professionals, so we make sure they are empowered with the tools they need to help our patients be successful. innovative technologies, advanced therapies, customized treatment plans, coordinated care teams – these are all part of our promise to deliver the highest level of care.
Organization | Encompass Health Corporation |
Employees | 22356 |
CEO | Mr. Mark J. Tarr |
Industry | Health Services |
Vanguard Ultra Short Bond Et
$78.62
-1.34%
Surgery Partners Inc
$78.62
-1.34%
Sl Green Realty Corp.
$78.62
-1.34%
Goldman Sachs Activebeta Int
$78.62
-1.34%
Allegro Microsystems, Inc.
$78.62
-1.34%
Cleanspark Inc
$78.62
-1.34%
Chart Industries Inc.
$78.62
-1.34%
Agree Realty Corp
$78.62
-1.34%
Joby Aviation Inc
$78.62
-1.34%